Spitalul Clinic Dr. I. Cantacuzino — Clinical Trial Site

22 Registered trials

9 Currently recruiting

Organisation

Spitalul Clinic Dr. I. Cantacuzino

Location

Bucharest, Romania

Identifier

ORG-100050107

Address

Strada Movila Ion 5-7, 020475, Romania

Departments

Clinical Internal Medicine and Rheumatology
Clinical Internal Medicine and Rheumatology/Hematologic IV Medullary Transplant Clinic -Fundeni
Departamentul de Gastroenterologie
Gastroenterologie
Gastroenterology
Gastroenterology and Endoscopy
Internal Medicine and Rheumatology
Internal Medicine and Rheumatology Department
Internal Medicine and Rheumatology II
Internal Medicine I
Medical Gastroenterology
Medicina Interna II
Rheumatology
Sectia Clinica Medicina Interna I

Clinical trials at this site (22)

Search interface

A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (P… Pending

2025-522471-28-00 psoriatic arthritis (PsA) 5
A study to test whether different doses of BI 3000202 help people with systemic lupus erythematosus (SLE) Pending

2025-523488-39-00 Systemic lupus erythematosus 4
A study to understand the safety and benefit of AlloNK® with rituximab in patients with hard-to-treat rheumatic diseases Recruiting

2025-520461-41-00 Systemic Sclerosis (SSc) 4 2025-10-22
A Phase 3, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil and Contezolid Compared … Recruiting

2022-500257-16-00 Diabetic Foot Infections 5 2023-03-17
Study that aims to investigate how effective and safe the use of a novel modified release tablet formulation of Colesevelam hydrochloride-MM… Recruiting

2024-511993-55-00 bile acid diarrhoea (BAD) 4 2025-09-18
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn’s Disease (CD) Recruiting

2024-518914-18-00 Moderate to Severely Active Ulcerative Colitis & Modera 4 2025-08-27
Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in participants With ANCA-associated Vasculitis Recruiting

2023-503184-42-00 Antineutrophil cytoplasmic antibody-associated vasculit 6 2025-07-28
A study to assess the efficacy and safety of efgartigimod PH20 SC in adults with systemic sclerosis (eSScape) Recruiting

2024-514539-67-00 Systemic Sclerosis 4 2025-06-27
A Study to Test the Effectiveness and Safety of RO7790121 for induction and maintenance therapy in Patients with Moderately to Severely Acti… Recruiting

2024-513053-69-00 Moderately to Severely Active Crohn's Disease (CD) 5 2025-04-16
A Phase 2b Study to Evaluate the Efficacy and Safety of Oral TAK-279 in Subjects with Moderately to Severely Active Crohn’s Disease Recruiting

2023-506704-14-00 Moderately to Severely Active Crohn's Disease 4 2024-09-04
A Long-Term Study of Elafibranor in Adult Participants with Primary Biliary Cholangitis (ELFIDENCE) Recruiting

2023-505251-43-00 Primary Biliary Cholangitis 5 2024-02-28
A study to find if tibulizumab works and how safe it is in participants with systemic sclerosis Ended

2024-519335-42-01 Systemic Sclerosis 4 2025-12-22
A Phase 2b to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With ACPA-Positive Rheumatoid Arthritis Ended

2024-515973-82-00 ACPA-Positive Rheumatoid Arthritis 4 2025-06-23
A study to investigate the efficacy and safety of subcutaneous sonelokimab versus placebo in participants aged 18 years and over with active… Ended

2024-516213-20-00 Psoriatic arthritis 5 2025-03-25
A Phase 2 Study of Obexelimab in Patients with Systemic Lupus Erythematosus Ended

2024-510584-37-00 Systemic Lupus Erythematosus 4 2024-10-22
A Study of Elafibranor in Adults with Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid Ended

2024-510695-20-00 Primary Biliary Cholangitis (PBC) 5 2024-10-15
A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Induction Study to Evaluate the Efficacy and Safety of Oral TAK-279 in … Ended

2023-506769-67-00 Moderate to Severely Active Ulcerative Colitis 4 2024-09-04
Determine effectiveness of Anifrolumab In Systemic sclerosis Ended

2023-505976-31-00 Systemic Sclerosis (SSc) presenting with Limited or Dif 5 2023-11-24
A Open-label Study to Evaluate the Efficacy, Safety, Tolerability of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis Ended

2023-509783-23-00 Diffuse Cutaneous Systemic Sclerosis 4 2023-02-24
A study in people with systemic sclerosis to test whether BI 685509 has an effect on lung function and other systemic sclerosis symptoms Ended

2022-500332-11-00 systemic sclerosis 4 2022-11-25
Open-label trial to check the safety and tolerability of RTX-GRT7039 injections for pain associated with osteoarthritis of the knee. Ended

2024-515709-24-00 Moderate to severe pain associated with Osteoarthritis 5 2022-07-26
A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis Ended

2023-509782-20-00 Diffuse Cutaneous Systemic Sclerosis 4 2021-11-11